Anna Gaulton
Overview
Explore the profile of Anna Gaulton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
7371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zdrazil B, Felix E, Hunter F, Manners E, Blackshaw J, Corbett S, et al.
Nucleic Acids Res
. 2023 Nov;
52(D1):D1180-D1192.
PMID: 37933841
ChEMBL (https://www.ebi.ac.uk/chembl/) is a manually curated, high-quality, large-scale, open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like properties, previously described in the 2012, 2014, 2017 and 2019...
2.
Magarinos M, Gaulton A, Felix E, Kiziloren T, Arcila R, Oprea T, et al.
PeerJ
. 2023 May;
11:e15153.
PMID: 37151295
The patent literature is a potentially valuable source of bioactivity data. In this article we describe a process to prioritise 3.7 million life science relevant patents obtained from the SureChEMBL...
3.
Nittinger E, Clark A, Gaulton A, Zdrazil B
J Cheminform
. 2023 Apr;
15(1):46.
PMID: 37069670
No abstract available.
4.
Gordillo-Maranon M, Zwierzyna M, Charoen P, Drenos F, Chopade S, Shah T, et al.
Nat Commun
. 2021 Oct;
12(1):6120.
PMID: 34675202
Drug target Mendelian randomization (MR) studies use DNA sequence variants in or near a gene encoding a drug target, that alter the target's expression or function, as a tool to...
5.
Leeson P, Bento A, Gaulton A, Hersey A, Manners E, Radoux C, et al.
J Med Chem
. 2021 May;
64(11):7210-7230.
PMID: 33983732
Physicochemical descriptors commonly used to define "drug-likeness" and ligand efficiency measures are assessed for their ability to differentiate marketed drugs from compounds reported to bind to their efficacious target or...
6.
Gaziano L, Giambartolomei C, Pereira A, Gaulton A, Posner D, Swanson S, et al.
Nat Med
. 2021 Apr;
27(4):668-676.
PMID: 33837377
Drug repurposing provides a rapid approach to meet the urgent need for therapeutics to address COVID-19. To identify therapeutic targets relevant to COVID-19, we conducted Mendelian randomization analyses, deriving genetic...
7.
Hunter F, Bento A, Bosc N, Gaulton A, Hersey A, Leach A
Chem Res Toxicol
. 2021 Jan;
34(2):385-395.
PMID: 33507738
The safety of marketed drugs is an ongoing concern, with some of the more frequently prescribed medicines resulting in serious or life-threatening adverse effects in some patients. Safety-related information for...
8.
Bento A, Hersey A, Felix E, Landrum G, Gaulton A, Atkinson F, et al.
J Cheminform
. 2021 Jan;
12(1):51.
PMID: 33431044
Background: The ChEMBL database is one of a number of public databases that contain bioactivity data on small molecule compounds curated from diverse sources. Incoming compounds are typically not standardised...
9.
Bosc N, Atkinson F, Felix E, Gaulton A, Hersey A, Leach A
J Cheminform
. 2021 Jan;
11(1):64.
PMID: 33430932
In response to Krstajic's letter to the editor concerning our published paper, we here take the opportunity to reply, to re-iterate that no errors in our work were identified, to...
10.
Bouhaddou M, Memon D, Meyer B, White K, Rezelj V, Marrero M, et al.
Cell
. 2020 Jul;
182(3):685-712.e19.
PMID: 32645325
The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an...